KristenNadeauMDMS

Pediatric Diabetes Endocrinology, Pediatric Obesity

Professor, Pediatric Endocrinology, University of Colorado School of Medicine; Research Director, Pediatric Endocrinology and Bariatric Surgery; Co-Chair, Clinical Investigations Core, NIH Diabetes Research Center; Director, Medical Student Longitudinal Mentored Research and Scholarly Activity Program; Pediatric Chair, Scientific Advisory and Review Committee;

Join to view full profile

Dr. Nadeau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nadeau's full profile

Already have an account?

Office
13123 E 16th Ave
Aurora, CO 80045
Phone+1 720-777-1234

Fax+1 720-777-7301

Education & Training

University of ColoradoFellowship, Pediatric Endocrinology, 2001 - 2004
Oregon Health & Science University (OHSU Health)Residency, Pediatrics, 1998 - 2001
University of Wisconsin School of Medicine & Public HealthClass of 1998

Certifications & Licensure

CO State Medical License 2002 - 2025
OR State Medical License 1999 - 2005
American Board of Pediatrics Pediatric Endocrinology

Clinical Trials

RISE Pediatric Medication Study Start of enrollment: 2013 Jun 16
Completed
Phase 3
EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes Start of enrollment: 2013 Mar 01
Completed
Phase 3
Metformin Therapy for Overweight Adolescents With Type 1 Diabetes Start of enrollment: 2013 Sep 01
Completed
Phase 3
Insulin Clamp Ancillary Study for Assessment of Insulin Resistance Start of enrollment: 2014 Jan 01
Completed
Phase 3
Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes Start of enrollment: 2015 Sep 01
Completed
Phase 2
Copeptin and Nonalcoholic Fatty Liver Disease Start of enrollment: 2018 Jun 19
Recruiting
Surgical or Medical Treatment Start of enrollment: 2019 Dec 15
Recruiting
Phase 4
Join now to see all

Publications & Presentations

PubMed

Pegloticase-Induced Rapid Uric Acid Lowering and Kidney and Cardiac Health Markers in Youth-Onset Type 2 Diabetes: A Pilot Clinical Trial.
Phoom Narongkiatikhun, Sungho Park, Amy Rydin, Callie Rountree-Jablin, Ye Ji Choi
Kidney Medicine. 2024-12-01
Proteomic Analysis Uncovers Multiprotein Signatures Associated with Early Diabetic Kidney Disease in Youth with Type 2 Diabetes Mellitus.
Laura Pyle, Ye Ji Choi, Phoom Narongkiatikhun, Kumar Sharma, Sushrut Waikar
Clinical Journal of the American Society of Nephrology. 2024-12-01
Differences in cardiorespiratory fitness by gonadotropin-releasing hormone agonist treatment before and after testosterone in transgender adolescents.
Natalie J Nokoff, Travis Nemkov, Samantha Bothwell, Melanie G Cree, Kelly N Z Fuller
Journal of Applied Physiology. 2024-11-01

Lectures

Atherogenic Lipoprotein Subfraction Cholesterol Profile in Adolescents with Type 1 Diabetes (T1D)
Aurora, CO - 6/16/2014
The Relationships among Alternative Markers of Glycemia and A1C, 2-hr PG, and Continuous Glucose Monitoring in Obese Adolescents
Aurora, CO - 6/14/2014
Phenotype of Insulin Resistance in Type 1 Diabetes Differs from the Typical Metabolic Syndrome Pattern
Aurora, CO - 6/15/2014

Press Mentions

New Study Suggests Bromocriptine Holds Promise for Preventing Heart Disease in Youth with Type 1 Diabetes — ScienceDailyDecember 6th, 2022
Parkinson's Medication Improved Blood Pressure in Teens with Type 1 DiabetesDecember 6th, 2022
American Diabetes Association Honors Two Outstanding CU Anschutz ResearchersApril 18th, 2022
Join now to see all